Pa. state Rep. Tony DeLuca took to the House floor to speak on a resolution designating August as Kidney Cancer Month in Pennsylvania. DeLuca, a cancer survivor, talked about how cancer impacts everyone's life in Pennsylvania. More at http://www.pahouse.com/DeLuca
Views: 30 Pa. House Video
Uplifting Athletes and PSU football team raise funds for kidney research through the annual Lift for Life event, held in State College, PA. In this video, Dr. David McDermott explains the importance of the Kidney Cancer SPORE.
Views: 70 Kidney Cancer
The Freedom Foundation would like to share with you... ...the story of Tracy and Hung. Hung is 48 and dying from metastatic kidney cancer that has spread to his lungs, brain and has just hit his bones. Instead of enjoying Hung's last few days or months together with their children (aged 15, 7 and 4) they are struggling to make ends meet whilst Hung and Tracy's relationship hangs in the balance with all the financial tension and lack of security for their 3 young boys. They often are forced to accept food parcels from charity organizations, their church and teachers at the children's school. If it wasn't for the help of those around them they wouldn't be able to feed their children. However, the biggest of their stress is coming from the mortgage payments of their home. They are behind on their mortgage and are at risk of the bank taking their home away. And of course...the banks "cant do anything about it". We believe they should be able to appreciate the little time they have left together, but instead they are stressed out by their financial hardship. We can't bear watching this and have decided to do something about it - because sending them food and day to day assistance takes the pain away for an instant but not for the lifetime that Hung still has left.. We have decided to take on the mammoth task of raising $402,535 to help them pay off their mortgage and Hung's funeral costs....but we need your help. Hung's dying wish is that his wife and beautiful children (who ask for nothing) can at least remain in their house when he dies - the peace of mind that his wife and children have the security of a roof over their head is all he wants...and has ever wanted. That being said - it took us over a week to get their approval to share their story...they never ask for anything and are the most grateful family we have ever met. Please consider donating ANY amount big or small. Lots of hands make light work. Lots of people donating small amounts will make a huge difference. MORE IMPORTANTLY, please share with all your friends on Facebook, email, text etc. THANK YOU SO MUCH !! *The Freedom Foundation focuses on charitable giving and assistance for those families who have fallen through the Safety Net. For these situations the Freedom Club alone doesn't have the ability to turn their financial situation around so we bring the community in for assistance.
Views: 609 MindShift.money
Dr. Ajuria completed his medical training at Temple University, graduate studies at the University of Pennsylvania, and his Fellowship in Nephrology at the George Washington University Hospital in Washington, D.C. He is Board Certified in Internal Medicine and Nephrology and co-authored two chapters in Nephrology and Hematology textbooks on "Hemodialysis Membrane Compatibility" and "The Anemia of Chronic Kidney Disease". Dr. Ajuria is currently Chief of Nephrology at Holy Cross Hospital. Dr. Ajuria's special areas of interest include: anemia of kidney failure, HIV infection and kidney disease, renal complications of inflammatory bowel disease, chronic kidney disease, acute kidney failure due to drug toxicity, and management of complicated hypertension. Dr. Ajuria is a native of Miami. He studied classical piano for 14 years including studies at the Eastman School of Music while obtaining an undergraduate degree at the University of Rochester in upstate New York. Dr. Ajuria has given several talks for the community and nursing staff at Holy Cross Hospital on Kidney Diseases as well as teaching fourth year medical students from Nova Southeastern Medical School. Among his numerous awards are consistently being named "Top Doctor" in Nephrology. He was also recently recognized as a "Top Performer" among "Best Doctors" by the U.S. News and World Report.
Views: 548 TheKidneyGroup
TITLE: Laparoscopic Partial Nephrectomy in a Solitary Kidney Introduction: Renal tumors in a solitary kidney are a unique management challenge. Techniques such as laparoscopic partial nephrectomy are more commonly being reported. Our video demonstrates a laparoscopic partial nephrectomy in a solitary kidney. Patients and Methods: Our 45-year-old male patient was diagnosed with left renal mass as an incidental finding. He has a prior history of right-sided Wilms tumor at 2 years of age. He underwent right nephrectomy and postoperative radiation therapy. His evaluation showed normal renal function. An abdominal CT scan showed a 17-mm mass at the upper pole of the left kidney. Due to the possibility of malignancy, surgery was advised. Laparoscopic left partial nephrectomy was performed. The patient was placed in the left side up position. A 12-mm and two 5-mm ports were placed in the left abdomen. Lysis of adhesions was done. Intraoperative ultrasound was used to identify the tumor margins. Dissection of the hilum revealed a single artery and vein, which were clamped using a vascular clamp. The mass was excised with 1cm of the surrounding normal tissue. A figure-of-eight stitch with Surgicel pledget and intracorporeal knot technique was used to close the bed. Total warm ischemia time was 25 minutes. The patient's postoperative course was unremarkable. One-week and 6-month follow-ups showed the patient in good health with normal creatinine. Conclusion: In select patients, minimally invasive techniques can be used for resection of a renal tumor in a solitary kidney. We successfully performed the partial nephrectomy laparoscopically with preservation of renal function. Abs# 10.305 Authors: Keyur Chavda, MD, Mohammad A. Bhatti, MD, Deepali Bobra, MD Guthrie Healthcare System, Sayre, Pennsylvania, USA
Views: 4493 SocietyLapSurgeons
According to a new study, surgeons at the University of Pennsylvania School of Medicine have been able to identify and remove cancerous nodules by making the cancerous tissue glow. The study involved the use of a near-infrared contrast agent, which makes tumor cells glow. Researchers combined PET imaging and IMI in 50 patients having surgery to remove lung nodules. Using this method, doctors have been able to identify as much as 91% of nodules, identifying some that were not previously undetected with just a PET scan alone. https://www.upi.com/Health_News/2017/07/28/Surgeons-use-glowing-tumor-technology-to-remove-hidden-cancer/5421501261071/ http://www.wochit.com This video was produced by YT Wochit News using http://wochit.com
Views: 300 Wochit News
Thanks for stopping by and watching my video! Please feel free to like, comment, and share with others in the car community to help spread the word about my channel! Also if you haven’t already, please subscribe for future car related content! In this video I attended the car show held at Steel City Harley Davidson in Washington, Pa hosted by the Blacktop Cannibals car club. Great event, nice people, cool hot rods and motorcycles. Also on my way home I spotted Andrew Driving his Orange "Driven to Cure" Liberty Walk GTR.. Check out Andrew and his amazing nonprofit organization to fight rare kidney cancer here: https://www.driventocure.org/ Music by Guggenz: https://soundcloud.com/guggenz Music by Ukiyo: http://soundcloud.com/ukiyoau/ Music by Sam Faye: https://soundcloud.com/osecan
Views: 68 Hayden Kehm
Dr. Haas, Director, Prostate and Kidney Cancer Program, Associate Professor of Medicine at the Hospital of the University of Pennsylvania, shares the latest thinking regarding TKIs in the treatment of renal cell cancer.
Views: 2 OBRoncology
This cancer gene therapy panel discussion sponsored by the Alliance for Cancer Gene Therapy (ACGT), featured heavyweights in the cancer field: Carl June, MD, the director of the Center for Cellular Immunotherapies at the Perelman School of Medicine at the University of Pennsylvania; George Yancopoulos, MD, PhD, president and chief scientific officer of Regeneron; Usman “Oz” Azam, MD, president and CEO of Tmunity Therapeutics; Andre Choulika, PhD, co-founder and CEO of Cellectis; and Rachel Elliott, a 21 year-old leukemia survivor and CAR T gene therapy recipient treated in Dr. June’s clinical trial at the Children’s Hospital of Philadelphia (CHOP). The panel was moderated by Meg Tirrell, biopharma reporter with CNBC. ACGT is the nation’s only charitable organization dedicated exclusively to funding cancer cell and gene therapy research and was one of the early funders of Dr. Carl June’s breakthrough CAR T gene therapy research at the University of Pennsylvania to treat leukemia. Dr. June received his first ACGT grant in 2004 and a second in 2008, back when gene therapy was considered a “risky proposition” according to Barbara Netter, ACGT’s co-founder. Fast forward to 2018 and the field has changed dramatically with major pharmaceutical companies and research institutions vying for the next big discovery using gene therapy or immunotherapy. April 10, 2018
Views: 350 ACGTFoundation
Dr. Haas, Director, Prostate and Kidney Cancer Program, Associate Professor of Medicine at the Hospital of the University of Pennsylvania, discusses how immunotherapies are being integrated into the treatment of renal cell cancer.
Views: 34 OBRoncology
My specialty in our practice and my research interest is minimally invasive surgery for cancers of the prostate, kidney, bladder and testis. In addition to general urology training, I have completed a sub-specialty training in laparoscopic and robotic surgery. I would specifically would like to call your attention to a laparoscopic partial nephrectomy as well as needle-ablation techniques for the treatment of kidney cancer. Using these techniques I am able to treat the cancer without removing the entire kidney, thus preserving the long term kidney function and avoiding the need for dialysis or transplantation. These new procedures are associated with minimal pain and often do not require admission to the hospital at all. However, these surgeries are technically very complex and therefore are only available in a few university medical centers around the country. For more Information contact Bryn Mawr Urology Group 610.525.6580 http://www.BrynMawrUrology.com
Views: 250 Brynmawr Urology
Dr. Ilia Zeltser - Pennsylvania Urologist Bryn Mawr Urology Group Minimally Invasive Surgery to treat all Urologic Conditions using a multidisciplinary approach to come up with treatment plane.
Views: 115 Brynmawr Urology
BBC London News 21 October 2016
Views: 46 I Am Incorrigible
A win against the DuPont Company awarded the plaintiff, Carla Bartlett, $1.6 million for negligence after she developed kidney cancer linked to the contamination of her drinking water by chemicals used in manufacturing DuPont’s Teflon products. Lindsay France speaks with Bartlett’s lawyer, Chris Paulos, about the legal strategies employed in taking on the chemical giant. Find RT America in your area: http://rt.com/where-to-watch/ Or watch us online: http://rt.com/on-air/rt-america-air/ Like us on Facebook http://www.facebook.com/RTAmerica Follow us on Twitter http://twitter.com/RT_America
Views: 3193 RT America
Naomi B. Haas, MD, director, Prostate and Kidney Cancer Program Associate Professor of Medicine at the Hospital of the University of Pennsylvania, discusses results of 2 ongoing clinical trials looking at adjuvant therapy options in renal cell carcinoma (RCC).
Views: 142 OncLiveTV
Dr. Haas, Director, Prostate and Kidney Cancer Program, Associate Professor of Medicine at the Hospital of the University of Pennsylvania, tells us how cabozantinib is being integrated into the treatment of previously untreated, advanced renal cell cancer patients.
Views: 30 OBRoncology
The Penn State Chapter becomes the first Uplifting Athletes Chapter to reach $1 million raised with its 2014 fundraising total of $151,990. The check presentation took places after the third quarter of the Ohio State vs. Penn State game.
Views: 6 Andy Shay
Beth Eaby-Sandy MSN, CRNP, OCN, of the Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA explains the different toxicities seen with immunotherapy compared to chemotherapy. Toxicities associated with immunotherapy are generally uncommon, but can be life threatening if they progress. It important for nurses to understand why these patients are having these toxicities, and how they differ from chemotherapy. Nurses must tell patients when to get in contact. Three of the most common severe immune-mediated toxicities from immunotherapies used in lung cancer are: pneumonitis, colitis, and rash/dermatitis. Pneumonitis and colitis are the two that can be life-threatening. Patients with pneumonitis may develop sudden in shortness of breath, chest tightness, or coughing. Such toxicities are reversible with high doses of steroids followed by about a months’ worth of a taper. Patients with colitis often confuse symptoms with diarrhea. The difference is that in diarrhea frequent and loose stools are seen. In colitis abdominal pain, cramping, with bloody or mucousy stools are seen. Colitis without treatment with high-dose steroids can rapidly become worse. It is important for HCPs to realize the greater concern of pneumonitis in lung cancer patients when compared to melanoma patients. The rash/dermatitis is not necessarily life-threatening. But it is important to evaluate with pictures, and possibly biopsy the skin lesion. This tends to be rare with lung cancer drugs, but more common and severe in melanoma with combinations of ipilimumab and nivolumab. Another wide range of common toxicities are endocrinopathies. Hypothyroidism causes TSH levels to go up meaning a need to supplement with levothyroxines (treatment of choice). Hyperthyroidism is less common and more difficult to treat. Hypophysitis, or pituitary or adrenal disorders, can also occur but are rare and treated accordingly with hormones or cortisol therapies. There are many other rare toxicities, for example ocular toxicities, neuromuscular toxicities. Hepatitis and nephritis are slightly more common but are ‘paper toxicities’, which patients don’t feel and can be managed. Recorded at the 2016 World Conference of Lung Cancer (WCLC) of the International Association for the Study of Lung Cancer (IASLC) in Vienna, Austria.
Views: 708 VJOncology
Dr. Zeltser received his bachelor's of science degree, Suma Cum Laude, from Brooklyn College and his medical degree with Distinction in Research from the State University of New York at Stony Brook School of Medicine. He completed both his general surgery and urology residencies at Thomas Jefferson University Hospital, in Philadelphia, Pennsylvania. He then completed a Fellowship in Minimally Invasive/Robotic Urologic Surgery at the University of Texas Southwestern Medical Center in Dallas, where he also served as Instructor in Urology. Currently Dr. Zeltser serves as a Clinical Assistant Professor of Urology at Thomas Jefferson University. Dr. Zeltser has an extensive experience in both "pure" laparoscopic and robotic (da Vinci) radical prostatectomies for prostate cancer as well as minimally invasive approaches to the treatment of kidney, bladder and testicular cancer. Dr. Zeltser is among an elite group of physicians nationwide and the only one in the Philadelphia region performing Laparoscopic Retroperitoneal Lymph Node Dissection, a safe and effective way to treat testicular cancer with decreased pain and faster recovery when compared to traditional surgical procedures. Dr. Zeltser's main clinical and research interests are in Endourology and the minimally invasive approaches to the treatment of kidney cancer and he has published numerous articles, abstracts and book chapters in the field of minimally invasive urology. Dr. Zeltser and colleagues reported the first ever single port scarless laparoscopic kidney removal. Dr. Zeltser is an active member of the American Urological Association, the Endourological Society and the American Medical Association. Dr. Zeltser is fluent in Russian. For more Information contact Bryn Mawr Urology Group 610.525.6580 http://www.BrynMawrUrology.com
Views: 1313 Brynmawr Urology
Allegheny General Hospital medical oncologist Dr. Jane Raymond talks to CBS in Pittsburgh (KDKA-TV) about a new study suggestion some common over the counter medications may increase the risk of kidney cancer.
Views: 7 Dan Laurent
Deepak Sudheendra, M.D., Assistant Professor of Clinical Radiology & Surgery, Hospital of the University of Pennsylvania, talks about tumor-directed treatment without incisions.
Views: 303 John Brune
Naomi B. Haas, MD of University of Pennsylvania presented "Experiences from the Bench to Bedside in Kidney Cancer". For more Winship Grand Rounds, visit https://winshipcancer.emory.edu/grand-rounds
Dr. Haas, Director, Prostate and Kidney Cancer Program, Associate Professor of Medicine at the Hospital of the University of Pennsylvania, discusses the optimal sequencing of agents in the treatment landscape for metastatic renal cell carcinoma (RCC).
Views: 12 OBRoncology
A brief overview of the Ninth Annual American Association for Cancer Research meeting in Philadelphia. This is billed as "The world's most comprehensive transdisciplinary cancer prevention meeting." Kidney Cancer Association CEO Bill Bro reports from the Pennsylvania Convention Center.
Views: 39 Kidney Cancer
To find a surgeon in Pittsburgh check the physician locator on www.davincisurgery.com da Vinci Surgical System used for precise minimally invasive surgery.
Views: 1089 Da Vinci
The Pennsylvania Immunization Coalition (PAIC), in partnership with 12 local immunization coalitions across the Commonwealth, launched the UDontGetIt campaign to increase vaccines among teens. The goal is to keep our adolescents healthy through immunizations, which have been called the most important health intervention in history, after safe drinking water. The truth is that vaccines have saved millions of lives over the years and prevented hundreds of millions of cases of disease. And, they're not just for infants and children! Immunizations are recommended throughout life. In addition to the yearly flu shot, there are three vaccines adolescents should get to protect against several serious and preventable diseases. These diseases can cause symptoms and complications such as brain damage, severe scarring, amputation of limbs, fever, lock jaw, seizures, irregular heartbeat, difficulty breathing, kidney damage, genital warts, cancer and even death. No teen should die from a disease that can be prevented. Teens need these 3 vaccines: TDAP: 1 dose Meningococcal Conjugate: 2 doses HPV: 3 doses For maximum protection, it's important to receive ALL follow-up doses of the vaccines. Make staying healthy a priority. Take control. Get it done. It's that important. Spread the word about the UDontGetIt campaign and use #UDontGetIt on Facebook and Twitter, when writing posts and tweets. Visit www.udontgetit.org to find out more!
Views: 5153 Pennsylvania Immunization Coalition
A leading Urologist from Tijuana, Mexico talks about kidney cancer and its treatments in this video. Many individuals opt for Partial Nephrectomy in Tijuana as an effective treatment to cure kidney cancer without removing it completely. It is a laparoscopic surgery of kidney that entails minimum bruises and pain. For more information and FREE Quote log on to www.mexicohealth.com
Views: 50 mexicohealth
Joshua Bauml, MD, assistant professor, Perelman School of Medicine, University of Pennsylvania, discusses combinations with immunotherapy for patients with head and neck cancer.
Views: 19 OncLiveTV
Watch an interview with Alan J. Wein, MD, PhD (Hon), Chief of Urology at the Hospital of the University of Pennsylvania, and the Founder's Professor of Urology, and the Chief of the Division of Urology at Penn Medicine. "Innovation has always been one of the strong suits here at Penn, and in urology we endeavor to translate innovative techniques into common clinical practice." "I see patients mostly with urologic cancer, that is carcinoma of the prostate, it's probably the most common thing I see. Every patient should get the benefit of the expertise of the institutions. So if you put together the expertise of the 15 people, we truly cover every single area in adult urology with someone who is truly an expert and specifically trained in that area as well as the other areas of adult urology." "We now have four fully-trained robotic surgeons on staff, and each of the three hospitals; Pennsylvania Hospital, Presbyterian Penn Medical Center and the Hospital, the University of Pennsylvania, has trained robotics surgeons there that can do cancer robotic surgery on prostate, on bladder, on kidney." "We like to think of ourselves as an organ preservation center where we can, so in other words, kidney-sparing operations for kidney cancer, bladder-sparing operations and protocols for bladder cancer, obviously, the application of proton therapy to prostate cancer, a huge innovation; the largest proton treatment center in the world right across the street there, you know, just waiting to accept prostate cancer patients who are applicable for that and who want that therapy over others." "We're constantly trying to apply what has been proven to be applicable, successful, effective, have minimal risks to our patients, not just with cancer but with every other malady that we treat. If something is new and exciting, if it has backup to show that it's effective, then we'll apply it in our patients. We'll be the first in the area to do that, always." "I'm Alan Wein. I'm the Chief of Urology here at the Hospital of the University of Pennsylvania, and the Founder's Professor of Urology, and the Chief of the Division of Urology at Penn Medicine." Learn more about Dr. Wein: http://www.pennmedicine.org/Wagform/MainPage.aspx?config=provider&P=PP&ID=1852 To learn more, visit http://www.pennmedicine.org/urology
Views: 5574 Penn Medicine
Dr. Haas, Director, Prostate and Kidney Cancer Program, Associate Professor of Medicine at the Hospital of the University of Pennsylvania, elaborates on what clinical evidence tells us about the adjuvant treatment of renal cell carcinoma (RCC) patients.
Views: 2 OBRoncology
Researchers at Penn Medicine, the Abramson Cancer Center and their partners at are conducting clinical trials that re-program t-cells to target and attack cancer.
Views: 2864 Penn Medicine
Researchers at the Perelman School of Medicine at the University of Pennsylvania reported men with prostate cancer going through radiation therapy can benefit from yoga. They found that general quality of life and side effects were stable throughout radiation therapy while participating in yoga. The side effects remaining stable include fatigue, sexual health and urinary incontinence. Fatigue from cancer is very different from everyday fatigue. Everyday fatigue can usually be solved with rest, however cancer-related fatigue has been reported to lower the patients’ quality of life even more so than pain. Sixty to 90 percent of patients undergoing radiation report having fatigue. Erectile dysfunction is another common symptom reported by 21 to 85 percent of patients. Yoga in prostate cancer patients has been shown to strengthen pelvic floor muscles, increase blood flow and reduce fatigue. Seventy two percent of people practicing yoga are female and 18 percent are over the age 55, while the median age of diagnosis for prostate cancer is 66. ------------------------------------------ Subscribe to our channel: http://read.ht/fLZ Follow us on Twitter: https://twitter.com/htTweets Like us on Facebook: https://www.facebook.com/hindustantimes Watch more videos at: http://www.hindustantimes.com/video hindustantimes.com © 2015
Views: 7829 Hindustan Times
In an NBC News exclusive, TODAY’s Savannah Guthrie sat down with Selena Gomez and her best friend, Francia Raisa, to talk about the kidney transplant that Gomez says saved her life after she was diagnosed with lupus five years ago. “My kidneys were just done,” Gomez says in the emotional interview. » Subscribe to TODAY: http://on.today.com/SubscribeToTODAY » Watch the latest from TODAY: http://bit.ly/LatestTODAY About: TODAY brings you the latest headlines and expert tips on money, health and parenting. We wake up every morning to give you and your family all you need to start your day. If it matters to you, it matters to us. We are in the people business. Subscribe to our channel for exclusive TODAY archival footage & our original web series. Connect with TODAY Online! Visit TODAY's Website: http://on.today.com/ReadTODAY Find TODAY on Facebook: http://on.today.com/LikeTODAY Follow TODAY on Twitter: http://on.today.com/FollowTODAY Follow TODAY on Google+: http://on.today.com/PlusTODAY Follow TODAY on Instagram: http://on.today.com/InstaTODAY Follow TODAY on Pinterest: http://on.today.com/PinTODAY Selena Gomez Speaks Out About Kidney Transplant From Her Best Friend Francia Raisa | TODAY
Views: 7086825 TODAY
http://preventdisease.com/news/13/021113_Foods-That-Kill-Cancer-And-Help-The-Body-Destroy-Tumours-Without-Any-Drugs.shtml live.psu.edu dailymail.co.uk sciencemag.org ehow.com 5 Foods That Kill Cancer And Help The Body Destroy Tumours Without Any Drugs Certain proteins within our immune system hold the precise instructions needed to destroy cancerous tumours. In a healthy body, this inherent ability is always present and always effective without the use of drugs. However, these proteins can be rendered ineffective if cells experience uncontrolled growth though damage or mutations to DNA or if toxins through food and chemical pollution override the immune system's natural function. Researchers from Pennsylvania State University have finally helped identify and support previous evidence which demonstrated how foods suppresses tumour development during immune surveillance, the immune system's process of patrolling the body for cancer cells. Those who subscribe to conventional cancer treatments such as chemotherapy and radiation have little understanding of how powerful the body is at healing itself if left to its own devices with the right nutrition. Scientists have recently found that healthy cells damaged by chemotherapy secreted more of a protein which boosts cancer cell survival. Chemotherapy has been proven to cause cancer cells to interact with nearby tumour cells and cause them to grow, invade, and importantly, resist subsequent therapy. In a study published in the journal Science Translational Medicine, scientists identified a molecule, known as TIC10, which activates a protein that helps fight the disease. The protein, called TRAIL (tumour-necrosis-factor-related apoptosis-inducing ligand) suppresses tumour development it can actually cross the blood-brain barrier, which separates the main circulatory system from the brain. Through the body's infinite wisdom, its systems recognize foreign invaders and poisons such as chemotherapy which are not beneficial for the brain. Many cancer drugs are consequently blocked from passing the blood-brain barrier. However, TRAIL is permitted passage due to its beneficial effects on the immune system. Another positive is that TIC10 does not just activate the TRAIL gene in cancerous cells, but also in healthy ones. This is known as the 'bystander effect' - i.e. where cells near cancerous cells are also killed. Nearby healthy cells are also given a boost to increase the number of cancer-killing TRAIL receptors on their cell surface. FOODS THAT INHIBIT TUMORS The key is to not succumb to selective cancer therapy or drug treatments based on clinical trials with artificially created versions of the protein. Food is the body's medicine, not drugs. All you need to do is seek those powerful foods which naturally inhibit tumor necrosis factor (TNF) of which there are several.
Views: 5477 Natural Remedies
The investigational transplantation approach described in this video is being studied in an ongoing clinical trial. Safety and efficacy of this approach has not been established, and therefore it is still unknown whether these patients will be cured. The research team plans to publish their full results upon completion of the trial. The study is supported by a research grant from the Merck Investigator Initiated Studies Program. Read more at http://www.uphs.upenn.edu/news/News_Releases/2016/09/thinker/.
Views: 1353 Penn Medicine News
Visit http://www.TryKangenNow.com or Jason @ 646-620-6896 to learn more about our Affordable Financing Options Free Next Day Delivery and Installation in New York (Manhattan, Queens, Staten Island, Bronx, Brooklyn, Long Island) Free Installation in Tri-State Area (New York, New Jersey, Pennsylvania) Seven Day Shipping anywhere in the continental United States Friend me on the following Social Media Sites: Facebook - http://www.facebook.com/jasonverdera Youtube -http://www.youtube.com/user/jasonverdera Linked In -- http://www.linkedin.com/pub/jason-verdera/8b/3b9/73 Pinterest - http://www.pinterest.com/jasonverdera/ Instagram - http://instagram.com/jasonverdera Twitter - http://twitter.com/JasonVerdera Kangen Water Homesite - http://www.TryKangenNow.com http://www.buykangenwaterdistributor.com http://www.buykangenwaterdistributor.net Brain Tumor and Lung Cancer Kangen Water Testimonial
Views: 29048 KangenTestimonials